Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Obseva Sa Ordinary Shares (OBSV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
ObsEva SA to Participate in Upcoming Investor Conferences

Geneva, Switzerland and Boston, MA - February 22, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 12.23 (+1.49%)
ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial

Geneva, Switzerland and Boston, MA - January 23, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 12.23 (+1.49%)
ObsEva SA Announces Completion of Patient Recruitment in PRIMROSE 2 Phase 3 Clinical Trial of Linzagolix for the Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids

Geneva, Switzerland and Boston, MA - December 21, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical- stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for...

OBSV : 12.23 (+1.49%)
ObsEva SA to Participate in BMO Healthcare Conference December 12, 2018

Geneva, Switzerland and Boston, MA - December 6, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 12.23 (+1.49%)
ObsEva SA to Host R&D Investor Day December 7, 2018

Geneva, Switzerland and Boston, MA - November 29, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics for...

OBSV : 12.23 (+1.49%)
ObsEva SA Announces Initiation of Phase 3 IMPLANT 4 Trial of Nolasiban in Europe, Canada and Russia for Improving IVF Outcomes

Geneva, Switzerland and Boston, MA - November 28, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 12.23 (+1.49%)
ObsEva SA (OBSV) Reports Q3 Loss, Misses Revenue Estimates

ObsEva SA (OBSV) delivered earnings and revenue surprises of 8.70% and -100.00%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?

OBSV : 12.23 (+1.49%)
ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

- IMPLANT 4 trial of nolasiban in IVF starting in Q4 2018, European MAA filing expected late 2019

OBSV : 12.23 (+1.49%)
ObsEva Sees Hammer Chart Pattern: Time to Buy?

ObsEva has been struggling lately, but the selling pressure may be coming to an end soon.

OBSV : 12.23 (+1.49%)
ObsEva SA to Hold Third Quarter 2018 Financial Results and Business Update Call on November 8, 2018

Geneva, Switzerland and Boston, MA -October 31, 2018 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics...

OBSV : 12.23 (+1.49%)
Report: Developing Opportunities within Just Energy Group, Tetra Technologies, Domtar, MacroGenics, ObsEva SA, and Magic Software Enterprises -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Just Energy Group, Inc....

MGNX : 21.88 (-1.57%)
MGIC : 8.42 (-1.29%)
OBSV : 12.23 (+1.49%)
UFS : 53.44 (-0.24%)
TTI : 2.50 (-5.66%)
JE : 3.55 (-1.11%)
ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018

ObsEva SA / ObsEva SA to Hold First Quarter 2018 Financial Results and Business Update Call on May 16, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 12.23 (+1.49%)
ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109)

ObsEva SA / ObsEva Announces Upcoming Presentations Related to its Endometriosis and Uterine Fibroid Development Programs with its Novel Oral GnRH Receptor Antagonist OBE2109 (KLH-2109) . Processed...

OBSV : 12.23 (+1.49%)
ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City

ObsEva SA / ObsEva SA to Host Key Opinion Leader Meeting on In Vitro Fertilization (IVF) April 26, 2018 in New York City . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely...

OBSV : 12.23 (+1.49%)
Analysis: Positioning to Benefit within Fortress Transportation and Infrastructure Investors, Turquoise Hill Resources, FactSet Research, Shaw Communications, El Pollo Loco, and ObsEva SA -- Research Highlights Growth, Revenue, and Consolidated Results

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Fortress Transportation and...

TRQ : 1.89 (-1.05%)
OBSV : 12.23 (+1.49%)
FDS : 227.99 (-0.01%)
FTAI : 15.92 (-0.19%)
SJR : 20.51 (-1.25%)
LOCO : 15.30 (-0.20%)
ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018

ObsEva SA / ObsEva SA to Participate in the H.C. Wainwright Annual Global Life Sciences Conference April 8-10, 2018 . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible...

OBSV : 12.23 (+1.49%)

Van Meerten Stock Picks

SecureWorks - Pick of the Day
My Stock Pick of the Day belongs to the security software company SecureWorks (SCWX).
SCWX +0.04
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar